November 3, 2006
Brigham Young U. Sues Pfizer for Fraud
Brigham Young University and one of its professors have accused Pfizer Inc. of fraud and misappropriation of trade secrets, among other things, in a lawsuit filed in the U.S. District Court in Salt Lake City. The complaint claims that the institution has lost at least $1-billion in profits from sales of the company's popular painkiller, Celebrex.
Celebrex belongs to a class of nonsteroidal anti-inflammatory drugs known as Cox-2 inhibitors, or "super aspirin."
According to the
This content is only for subscribers. You can gain access by purchasing a:
Print Subscription
Digital Subscription
Already have an account? Log In Now.
-
The Chronicle Review
-
Government
-
Advice
